Ellington Management Group’s Medtronic MDT Stock Holding History

Ellington Management Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,100	Closed	-$497K	–	701
2019 Q2	$497K	Sell	5,100 -4,800	-48%	-$438K	0.08%	237
2019 Q1	$902K	Buy	+9,900	New	+$886K	0.16%	154
2018 Q4	–	Sell	-8,000	Closed	-$787K	–	518
2018 Q3	$787K	Buy	+8,000	New	+$740K	0.21%	139
2018 Q1	–	Sell	-17,300	Closed	-$1.4M	–	949
2017 Q4	$1.4M	Buy	+17,300	New	+$1.39M	0.23%	53
2017 Q3	–	Sell	-3,000	Closed	-$266K	–	757
2017 Q2	$266K	Buy	+3,000	New	+$253K	0.04%	443
2016 Q4	–	Sell	-4,400	Closed	-$380K	–	704
2016 Q3	$380K	Buy	+4,400	New	+$383K	0.1%	373
2014 Q3	–	Sell	-10,800	Closed	-$689K	–	398
2014 Q2	$689K	Buy	+10,800	New	+$656K	0.32%	47
2013 Q4	–	Sell	-4,000	Closed	-$213K	–	696
2013 Q3	$213K	Buy	+4,000	New	+$215K	0.04%	645

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellington Management Group's MDT Position: Q3 2019 in Review

Ellington Management Group sold out of Medtronic (MDT) in Q3 2019, closing a stake of 5,100 shares — an estimated $497K sold.

Ellington Management Group first reported a position in MDT in Q3 2013 and held it in 8 quarters. The position peaked at $1.4M in Q4 2017. 1,644 funds tracked by Wall St. Rank hold MDT as of Q3 2019.

Ellington Management Group reported no remaining Medtronic position as of Q3 2019 after selling out during the quarter.
Ellington Management Group sold 5,100 Medtronic shares in Q3 2019, an estimated $497K.
Ellington Management Group first reported a position in Medtronic in Q3 2013 and held it in 8 quarters.
Ellington Management Group's Medtronic position peaked at $1.4M in Q4 2017.
1,644 funds tracked by Wall St. Rank held Medtronic as of Q3 2019.

Based on Ellington Management Group's 13F filing for Q3 2019, filed 14 Nov 2019.